SKYD Short Interest Hits Year High as Analysts Turn
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Short interest in SKYD has climbed to its highest level in at least a year, with 144.6 million shares now sold short, up 76% from a month ago. Yet the stock has outperformed its closest correlated peers by a wide margin: SKYD gained 2.3% over the past week while TSQ dropped 22%, WIMI fell 17%, and PUBM lost 8%. That divergence sets a charged backdrop for the November 4 print.
The borrow market reflects the growing short position. Availability has tightened to 33.6%, down sharply from 160% in mid-September, meaning there are now roughly one-third of a share available for every share already on loan. The 52-week low sits at 19.4%, hit on October 15, so the lending pool has loosened somewhat but remains compressed. Borrowing costs pulled back to 1.88% after touching 3.4% earlier in October, a modest easing. Options traders have moved in the opposite direction from short sellers: the put/call ratio has dropped to 0.52, well below its 20-day average of 0.68, with call volume dominant every session since October 21. That positioning is more consistent with upside speculation than defensive hedging.
The analyst picture reinforces that split. Citigroup reinstated with a Buy and a $10 target on October 26, and JP Morgan upgraded to Neutral with a $9 target on October 23, the first constructive moves after a run of cuts that saw Bernstein halve its target to $6 and Barclays trim to $7. The panel mean now stands at $8.87, above the $7.95 close, implying roughly 12% upside at consensus. The bull case is built around the merged entity's $6 billion-plus cost synergy target, DTC profitability of $251 million adjusted EBITDA, and Studios EBITDA that doubled in the most recent quarter. The bear case is equally concrete: $79 billion of pro forma net debt, theatrical output obligations where missed targets trigger $30 million per-film penalties, and affiliate revenue in structural decline as linear TV erodes.
The ownership register adds another layer of context. Director Gerald Cardinale received share grants totalling $4 billion at $12 on October 6, and Director Laurene Powell Jobs took 20.8 million shares at the same price. Both paid 51% above where the stock trades today. Redbird Capital, the largest identified holder with 8.7% of shares, added 333 million shares as of October 6. These are grant and acquisition transactions at the merger close rather than open-market purchases, so the signal is different from a discretionary buy. Still, the concentration of newly issued stock in insider and founder hands, at a price far above the current level, is not a neutral fact heading into the first full quarterly report as a combined company.
The November 4 report is the first real test of whether the synergy and leverage targets set out at deal close can survive contact with actual quarterly numbers.
Stocks in this article
See the live data behind this article on ORTEX.
Open SKYD on ORTEX →How this article was generated
- Generated
- 1 Nov 2026, 04:29
- Data as of
- 1 Nov 2026, 04:05
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.